Skip to main content
Premium Trial:

Request an Annual Quote

Quanterix Raises $15M in Private Funding

NEW YORK (GenomeWeb News) – Quanterix, a privately held firm developing a single molecule array technology, said today that it has closed a second tranche of its Series A financing round, bringing in a total of $15 million.
The Cambridge, Mass.-based firm said that proceeds from the round of financing would be used to validate its platform and accelerate development of ultrasensitive assays targeting a variety of biological analytes. Quanterix said that it is developing the single molecule array (SiMoA) technology for clinical diagnostic, drug development, and life science research applications.
The company was founded last year by David Walt, a professor at Tufts University, and Nicholas Naclerio, a life sciences industry veteran, who previously served as president of ParAllele BioScience and led the commercial launch several years ago of Motorola’s CodeLink microarray platform. Naclerio, who is serving as chairman and interim CEO of Quanterix, also was on the board of privately held True Materials, which was recently acquired by Affymetrix.
Quanterix holds an exclusive license to an intellectual property portfolio covering the SiMoA technology from Walt’s laboratory at Tufts.
Investors in the round included Arch Venture Partners, Bain Capital Ventures, and Flagship Ventures.
“We see tremendous value and promise for this technology,” Keith Crandell, a member of Quanterix’s board and a co-founder and managing director of Arch Venture Partners, said in a statement. “The ability to quantify biomarkers present at low concentrations in blood could provide critical information to clinicians and help guide health care decisions.”
Quanterix is currently developing protein biomarker-based assays for cancer, chronic inflammatory disease, and cardiovascular disease.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.